SULT2B1 and cardiomyopathy: Additionally, the variant SULT2B1-rs10426628 was associated with a 1.9-fold increased risk of cardiomyopathy in the combined cohort (95% CI: 1.2–2.5, p = 3.2 × 10−4) [22].